MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 40 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $13,000 | -40.9% | 79,800 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $22,000 | +29.4% | 79,800 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $17,000 | +70.0% | 79,800 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $10,000 | -65.5% | 79,800 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $29,000 | -23.7% | 79,800 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $38,000 | -5.0% | 79,800 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $40,000 | -21.6% | 79,800 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $51,000 | -19.0% | 79,800 | 0.0% | 0.00% | -20.0% |
| Q2 2022 | $63,000 | -1.6% | 79,800 | 0.0% | 0.01% | +25.0% |
| Q1 2022 | $64,000 | -21.0% | 79,800 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $81,000 | -22.1% | 79,800 | 0.0% | 0.01% | -28.6% |
| Q3 2021 | $104,000 | +67.7% | 79,800 | 0.0% | 0.01% | +75.0% |
| Q2 2021 | $62,000 | -26.2% | 79,800 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $84,000 | -22.9% | 79,800 | 0.0% | 0.01% | -33.3% |
| Q4 2020 | $109,000 | +78.7% | 79,800 | 0.0% | 0.01% | +80.0% |
| Q3 2020 | $61,000 | -1.6% | 79,800 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $62,000 | +29.2% | 79,800 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $48,000 | -73.5% | 79,800 | 0.0% | 0.01% | -66.7% |
| Q4 2019 | $181,000 | +262.0% | 79,800 | 0.0% | 0.02% | +260.0% |
| Q3 2019 | $50,000 | -26.5% | 79,800 | 0.0% | 0.01% | -28.6% |
| Q2 2019 | $68,000 | -21.8% | 79,800 | 0.0% | 0.01% | -22.2% |
| Q1 2019 | $87,000 | +85.1% | 79,800 | 0.0% | 0.01% | +50.0% |
| Q4 2018 | $47,000 | -35.6% | 79,800 | 0.0% | 0.01% | -25.0% |
| Q3 2018 | $73,000 | +108.6% | 79,800 | 0.0% | 0.01% | +100.0% |
| Q2 2018 | $35,000 | -42.6% | 79,800 | 0.0% | 0.00% | -42.9% |
| Q1 2018 | $61,000 | -34.4% | 79,800 | 0.0% | 0.01% | -36.4% |
| Q4 2017 | $93,000 | -11.4% | 79,800 | 0.0% | 0.01% | -15.4% |
| Q3 2017 | $105,000 | -22.2% | 79,800 | 0.0% | 0.01% | -23.5% |
| Q2 2017 | $135,000 | -38.9% | 79,800 | 0.0% | 0.02% | -41.4% |
| Q1 2017 | $221,000 | +190.8% | 79,800 | -11.1% | 0.03% | +123.1% |
| Q4 2015 | $76,000 | +2.7% | 89,800 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $74,000 | +146.7% | 89,800 | +201.3% | 0.01% | +160.0% |
| Q2 2015 | $30,000 | +87.5% | 29,800 | 0.0% | 0.01% | +66.7% |
| Q1 2015 | $16,000 | – | 29,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 10,188,312 | $8,727,000 | 0.75% |
| Vivo Capital, LLC | 6,818,181 | $5,840,000 | 0.55% |
| Stonepine Capital Management, LLC | 668,615 | $573,000 | 0.40% |
| Telemetry Investments, L.L.C. | 574,619 | $492,000 | 0.38% |
| Broadfin Capital, LLC | 766,708 | $657,000 | 0.14% |
| Granite Point Capital Management, L.P. | 1,500,000 | $1,285,000 | 0.09% |
| STALEY CAPITAL ADVISERS INC | 200,000 | $171,000 | 0.01% |
| HYMAN CHARLES D | 79,800 | $68,000 | 0.01% |
| CRA Financial Services, LLC | 10,000 | $9,000 | 0.01% |
| BRIGHTON JONES LLC | 50,000 | $43,000 | 0.01% |